The effects of bretylium on experimental cardiac dysrhythmias.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001158:Arteries / Q000601:surgery; D001794:Blood Pressure / Q000187:drug effects; D001949:Bretylium Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003331:Coronary Vessels / Q000601:surgery; D004285:Dogs; D004837:Epinephrine / Q000009:adverse effects; D006221:Halothane / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D007275:Injections, Intravenous; D008026:Ligation; D010042:Ouabain / Q000494:pharmacology; D013610:Tachycardia / Q000139:chemically induced; D014693:Ventricular Fibrillation / Q000188:drug therapy
D001949:Bretylium Compounds; D010042:Ouabain; D006221:Halothane; D004837:Epinephrine